Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular …
H Watanabe, C van der Werf, F Roses-Noguer, A Adler… - Heart rhythm, 2013 - Elsevier
BACKGROUND: Conventional therapy with beta-blockers is incompletely effective in
preventing arrhythmic events in patients with catecholaminergic polymorphic ventricular …
preventing arrhythmic events in patients with catecholaminergic polymorphic ventricular …
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia
C van der Werf, PJ Kannankeril, F Sacher… - Journal of the American …, 2011 - jacc.org
Objectives: This study evaluated the efficacy and safety of flecainide in addition to
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …
Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial
Importance Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially
lethal genetic arrhythmia syndrome characterized by polymorphic ventricular tachycardia …
lethal genetic arrhythmia syndrome characterized by polymorphic ventricular tachycardia …
Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia
EK Biernacka, P Hoffman - Europace, 2011 - academic.oup.com
Discussion Catecholaminergic polymorphic VT is a familial electrical disorder characterized
by exercise-and stress-related ventricular arrhythmias in the absence of structural heart …
by exercise-and stress-related ventricular arrhythmias in the absence of structural heart …
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade
GJ Padfield, L AlAhmari, KVV Lieve, T AlAhmari… - Heart Rhythm, 2016 - Elsevier
Discussion We describe our initial experience of patients with RyR2-positive CPVT
successfully treated with flecainide monotherapy because of β-blocker intolerance. None of …
successfully treated with flecainide monotherapy because of β-blocker intolerance. None of …
Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia
AT Bergeman, KVV Lieve, D Kallas, JM Bos… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: In severely affected patients with catecholaminergic polymorphic
ventricular tachycardia, beta-blockers are often insufficiently protective. The purpose of this …
ventricular tachycardia, beta-blockers are often insufficiently protective. The purpose of this …
[HTML][HTML] The role of flecainide in the management of catecholaminergic polymorphic ventricular tachycardia
KVV Lieve, AA Wilde, C van der Werf - … & electrophysiology review, 2016 - ncbi.nlm.nih.gov
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but severe genetic
cardiac arrhythmia disorder, with symptoms including syncope and sudden cardiac death …
cardiac arrhythmia disorder, with symptoms including syncope and sudden cardiac death …
Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature
C Pott, DG Dechering, F Reinke, A Muszynski… - Europace, 2011 - academic.oup.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited
arrhythmogenic disease that can cause sudden cardiac death due to ventricular fibrillation …
arrhythmogenic disease that can cause sudden cardiac death due to ventricular fibrillation …
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia
A Khoury, I Marai, M Suleiman, M Blich, A Lorber… - Heart rhythm, 2013 - Elsevier
Background Calsequestrin-associated catecholaminergic polymorphic ventricular
tachycardia (CPVT2) can cause sudden death in young individuals in response to stress …
tachycardia (CPVT2) can cause sudden death in young individuals in response to stress …
High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade …
KH Haugaa, IS Leren, KE Berge, J Bathen… - Europace, 2010 - academic.oup.com
Aim Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited cardiac
disease predisposing to life-threatening arrhythmias. We aimed to determine the prevalence …
disease predisposing to life-threatening arrhythmias. We aimed to determine the prevalence …
相关搜索
- ventricular arrhythmias flecainide therapy
- efficacy of flecainide ventricular tachycardia
- ventricular tachycardia selected patients
- ventricular tachycardia arrhythmic events
- ventricular tachycardia β blockade
- ventricular tachycardia lower incidence
- ventricular tachycardia family members
- ventricular tachycardia high prevalence
- ventricular tachycardia large cohort
- ventricular tachycardia successful treatment
- ventricular tachycardia flecainide therapy
- ventricular arrhythmias effects of flecainide
- ventricular tachycardia flecainide in a patient
- ventricular tachycardia effects of flecainide
- ventricular tachycardia flecainide in the treatment